Shrinking lung syndrome: recognition, pathophysiology and therapeutic strategy
Authors:
- 1 February 2011
- journal article
- Published by Taylor & Francis in Expert Review of Respiratory Medicine
- Vol. 5 (1) , 33-39
Abstract
(2011). Shrinking lung syndrome: recognition, pathophysiology and therapeutic strategy. Expert Review of Respiratory Medicine: Vol. 5, No. 1, pp. 33-39.Keywords
This publication has 40 references indexed in Scilit:
- Off‐label use of rituximab in a tertiary Queensland hospitalInternal Medicine Journal, 2010
- Successful Treatment of Shrinking Lung Syndrome With Rituximab in a Patient With Systemic Lupus ErythematosusJCR: Journal of Clinical Rheumatology, 2010
- Ventilatory failure in shrinking lung syndrome is associated with reduced chest complianceInternal Medicine Journal, 2010
- Efficacy and safety of rituximab in moderately‐to‐severely active systemic lupus erythematosus: The randomized, double‐blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trialArthritis & Rheumatism, 2009
- Clinical and immunological manifestations in 624 SLE patients in Saudi ArabiaLupus, 2009
- A retrospective seven‐year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at university college london hospital: The first fifty patientsArthritis Care & Research, 2009
- Shrinking lungs syndrome, a rare manifestation of systemic lupus erythematosusInternational Journal Of Clinical Practice, 2006
- Shrinking Lung Syndrome in a 14-Year-Old Boy with Systemic Lupus ErythematosusPediatric Pulmonology, 2005
- Shrinking Lung Syndrome in Systemic Lupus Erythematosus and Sjogren’s SyndromeJCR: Journal of Clinical Rheumatology, 2002
- A case of the "shrinking lung syndrome" in SLE. Improvement with corticosteroid therapy.Japanese Journal of Clinical Immunology, 1996